Insights into IL-1 family cytokines in kidney allograft transplantation: IL-18BP and free IL-18 as emerging biomarkers
Language English Country Great Britain, England Media print-electronic
Document type Journal Article
PubMed
38801805
DOI
10.1016/j.cyto.2024.156660
PII: S1043-4666(24)00163-7
Knihovny.cz E-resources
- Keywords
- Acute rejection, Allograft, Cytokines, IL-1 family, Kidney, Transplantation,
- MeSH
- Allografts * MeSH
- Biomarkers * blood MeSH
- Adult MeSH
- Transplantation, Homologous methods MeSH
- Interleukin-1 blood MeSH
- Interleukin-18 * blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Intercellular Signaling Peptides and Proteins blood MeSH
- Prospective Studies MeSH
- Graft Rejection * immunology blood MeSH
- Kidney Transplantation * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Biomarkers * MeSH
- IL18 protein, human MeSH Browser
- Interleukin-1 MeSH
- interleukin-18 binding protein MeSH Browser
- Interleukin-18 * MeSH
- Intercellular Signaling Peptides and Proteins MeSH
Proinflammatory cytokines and their inhibitors are involved in the regulation of multiple immune reactions including response to transplanted organs. In this prospective study, we evaluated changes in serum concentrations of six IL-1 family cytokines (IL-1 alpha, IL-1 beta, IL-1RA, IL-18, IL-18BP, and IL-36 beta) in 138 kidney allograft recipients and 48 healthy donors. Samples were collected before transplantation and then after one week, three months and one year, additional sera were obtained at the day of biopsy positive for acute rejection. We have shown, that concentrations of proinflammatory members of the IL-1 family (IL-1β, IL-18, IL-36 β) and anti-inflammatory IL-18BP decreased immediately after the transplantation. The decline of serum IL-1RA and IL-1α was not observed in subjects with acute rejection. IL-18, including specifically its free form, is the only cytokine which increase serum concentrations in the period between one week and three months in both groups of patients without upregulation of its inhibitor, IL-18BP. Serum concentrations of calculated free IL-18 were upregulated in the acute rejection group at the time of acute rejection. We conclude that IL-1 family cytokines are involved mainly in early phases of the response to kidney allograft. Serum concentrations of free IL-18 and IL-18BP represent possible biomarkers of acute rejection, and targeting IL-18 might be of therapeutic value.
References provided by Crossref.org